Artículos científicos Open Access

Single-domain antibodies make a difference
Science
Xavier Saelens and Bert Schepens
Saliva for Detection of SARS-CoV-2
NEJM
Anne L. Wyllie, et al
Redeploying Covid-19 Payment Reforms for Biomedical Innovation: A New Opportunity for the Value Movement
NEJM Catalyst
Kushal T. Kadakia, MSc, Adam L. Beckman, BS & Aaron S. Kesselheim, MD, JD, MPH
Avoiding a legacy of unequal non-communicable disease burden after the COVID-19 pandemic
The Lancet Diabetes & Endocrinology
Nason Maani, Salma M Abdalla, Sandro Galea
The impact of the COVID-19 lockdown on HIV care in 65 South African primary care clinics: an interrupted time series analysis
The Lancet HIV
Jienchi Dorward, Thokozani Khubone, Kelly Gate, Hope Ngobese, Yukteshwar Sookrajh, Siyabonga Mkhize, and others
Comparative cost-effectiveness of SARS-CoV-2 testing strategies in the USA: a modelling study
The Lancet Public Health
Zhanwei Du, Abhishek Pandey, Yuan Bai, Meagan C Fitzpatrick, Matteo Chinazzi, Ana Pastore y Piontti, and others
WHO international non-proprietary names: the need to distinguish COVID-19 vaccines
The Lancet
Ursula Loizides, Akinola Adisa, Ana López de la Rica Manjavacas, James S Robertson, Raffaella Balocco
Breastfeed or be vaccinated—an unreasonable default recommendation
The Lancet
Anne Merewood, Lars Bode, Riccardo Davanzo, Rafael Perez-Escamilla
A COVID-19 jab in the right direction
The Lancet
A Mark Clarfield, Karl Skorecki, Orly Manor, Shimon Glick
Ageing in a post COVID world
The Lancet Healthy Longevity
The Lancet Healthy Longevity
Lessons and risks of medical device deployment in a global pandemic
The Lancet Global Health
Rebecca J Shipley, David Brealey, Rashan Haniffa, Clare Elwell, Tim Baker, David A Lomas, and others
Inactivated COVID-19 vaccines to make a global impact
The Lancet Infectious Diseases
Patrick L Iversen, Sina Bavari

Página 207 de 490

Síguenos en nuestras redes sociales

Suscríbete a nuestro Boletín Institucional
INSP logo
© 2022 INSP. Todos los derechos reservados.